IN PREPARATION for the imminent upscheduling of products containing codeine in Feb 2018, Amcal Pharmacies are rolling out tailored pain management plans for patients.
Amcal senior pharmacist James Nevile (pictured) applauded Pharmacists for both their support and advice to patients seeking relief from all types of pain, and their work with local GP's to find appropriate long-term solutions.
"We've been working behind the scenes to make sure pharmacists are well-prepared with access to a huge range of resources including process and training guides, checklists to prepare for the changeover date, dialogue guides and FAQs."
Also available to Amcal Pharmacy members will be the database S.H.E.R.P.A. (Sigma Holistic Evidence References and Patient Advice) launched in Mar this year (PD 07 Mar) to personalise evidence-based pain management plans for consumers, Nevile added.
MEANWHILE, Pain Australia says it has been hard at work developing a codeine fact sheet and infographic as well as a joint 'myth buster' fact sheet (CLICK HERE) with the Royal Australasian College of Physicians.
"It has been a time of considerable mainstream and social media follow up on this issue, which will continue as Feb draws closer," a spokesperson said.
The above article was sent to subscribers in Pharmacy Daily's issue from 15 Dec 17
To see the full newsletter, see the embedded issue below or CLICK HERE to download Pharmacy Daily from 15 Dec 17
